Kreimen Tablets

Adult dose

A thorough general examination and gynecological examination should be performed before taking this medicine. During long-term use of this medicine, regular examinations every 6 months are recommended. Take 1 white tablet daily for the first 11 days, followed by 1 pink tablet daily for the next 10 days. Take this medicine with an adequate amount of water. 1. When starting treatment 1) If you menstruate regularly: Start taking this medicine on day 5 of your menstrual cycle (the first day of menstruation = day 1 of the menstrual cycle). 2) If your menstrual cycle is irregular or you are already postmenopausal: You may start taking this medicine immediately. 2. Continuing treatment Take this medicine for 21 days, then stop taking it for 7 days. Withdrawal bleeding similar to menstruation occurs about 2-4 days after taking the last tablet. Unless otherwise instructed by your doctor, after the 7-day break, start taking the medicine from a new pack right away. The day you start will be the same day of the week as when you first started the previous pack. If withdrawal bleeding does not occur during the 7-day break, do not start taking the medicine from a new pack until pregnancy has been ruled out. Take this medicine at approximately the same time every day (e.g., with breakfast). However, if you miss your usual dose time, you may take it within 12 hours. 3. If you forget to take a dose If you miss a dose, take it as soon as possible. If more than 24 hours have passed, there is no need to take an extra tablet. If you have missed doses for several days, bleeding may occur. Bleeding generally occurs within a few days before the last dose or during the first week of taking the medicine from the next pack. 2) Older adults There are no study results suggesting that dose adjustment is necessary in older adults. 3) Patients with hepatic impairment This medicine has not been specifically studied in patients with hepatic impairment. This medicine should not be used in women with liver tumors or a history of liver tumors, or in women with severe liver disease. Women with impaired liver function require close supervision, and hormone replacement therapy should be discontinued if indicators of liver function worsen. (See Precautions for Use.) 4) Patients with renal impairment This medicine has not been specifically studied in patients with renal impairment.

Child dose

Children and adolescents: This medicine is not for use in children and adolescents.

This medicine should be discontinued immediately and a doctor consulted if any severe symptoms or conditions occur. For example, if sudden severe headaches or visual or auditory disturbances, leg pain or swelling, chest pain occur, treatment should be stopped immediately. Discontinuation should also occur when approaching surgery, in an immobile state, showing liver dysfunction symptoms (jaundice, hepatitis), generalized itching, increased seizures, elevated blood pressure, or during pregnancy or breastfeeding. Additionally, individuals with hypersensitivity to this medicine, severe liver dysfunction, liver tumors, thrombotic diseases, a history of breast cancer, pregnant women, or patients with severe hypertension should not use this medicine. This medicine should be administered cautiously in patients with smooth muscle tumors, endometriosis, risk factors for thrombosis, hypertension, diabetes, migraine, depression, cardiac or renal function impairments, and regular check-ups are required during treatment. During use, side effects such as headaches, dizziness, nausea, skin rashes, breast pain, swelling, and fatigue may occur, so if symptoms are severe or persistent, consult a doctor. This medicine is not a contraceptive, and blood pressure, blood sugar, liver function tests, and gynecological examinations must be performed before and during treatment. In particular, if irregular bleeding persists, a thorough examination by a gynecologist is required. This medicine may interact with other medications, so inform your doctor or pharmacist if you are taking other drugs, as some medications may reduce or increase the effectiveness of this medicine. Women who are pregnant or possibly pregnant or breastfeeding should not use this medicine and should stop taking it immediately upon confirmation of pregnancy. In case of overdose, symptoms such as breast tension, abdominal bloating, anxiety, and nausea may occur, and these symptoms usually resolve after discontinuing the drug. This medicine must be kept out of the reach of children and stored in the original container to prevent misuse or quality deterioration. When taking, it should be taken exactly according to the days and order indicated on the packaging, one tablet daily for 21 days.

hypersensitivity, weight gain, weight loss, depressed mood, anxiety, decreased libido, increased libido, headache, dizziness, migraine, visual disturbances, intolerance to contact lenses, palpitations, abdominal pain, nausea, indigestion, abdominal bloating, vomiting, rash, itching, nodular erythema, urticaria, hirsutism, acne, muscle cramps, petechial bleeding including uterine bleeding, breast pain, breast tenderness, dysmenorrhea, vaginal discharge, premenstrual syndrome, breast size increase, edema, fatigue, restlessness, persistent fever, gastrointestinal disturbances, abdominal cramps, changes in liver function, cholestatic jaundice, hepatic adenoma, non-jaundice hepatitis, breast tension, benign breast disease, galactorrhea, amenorrhea during prolonged withdrawal period, uterine tumors, persistent vaginal dryness, menstrual irregularities, cardiovascular diseases, thromboembolism, liver spots, acanthosis nigricans, inflammation of the eye due to contact lenses, hearing impairment, worsening of epilepsy, retention of sodium and water, hypertension, pain, purpura, breast discomfort, irregular bleeding, fluid retention, syndrome of inappropriate antidiuretic hormone secretion

This medicine should be stored in a tightly sealed container to prevent air or moisture from entering, and it is important to maintain a storage temperature between 1 and 30 degrees Celsius. Storing in this manner will help maintain the medicine's effectiveness.

Appearance

This medicine is a round, white, convex tablet on both sides. This medicine is a round, pink, convex tablet on both sides.

Package unit

21 tablets/box [21 tablets x PTTP]